IP Library › Granted Patent US 7,135,490
Granted Patent B2
US 7,135,490 · App. 10/676,118 · Granted Nov 14, 2006

Method for the treatment of glomerulonephritis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,135,490
App. No.
10/676,118
Granted
Nov 14, 2006
Kind
B2
Abstract

A treatment for glomerulonephritis is disclosed comprising administering (±)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1 -[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate.

Claims (1)

1. A method for the treatment of glomerulonephritis in a mammal comprising the step of administering to a mammal in need thereof a pharmaceutically effective amount of (±)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate or a salt thereof.

Assignments (1)
CHANGE OF NAME Recorded Mar 9, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 015864/0954 →